Browse: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 3 |
Clark & Elbing LLP patentsThe following is a sampling of recent Clark & Elbing LLP patent applications (USPTO Patent Application #, Patent Title) sorted by month.
July 2009 - Clark & Elbing LLP patents
20090175797 - Inflammation-inhibitory serum factors and uses thereof
20090176743 - Methods for treating or preventing reactivation of a latent herpesvirus infection
20090165876 - Microfluidic structures
20090166562 - Production of microfluidic devices using laser-induced shockwaves
20090169512 - Vaccinia virus strains
20090170767 - Soluble endoglin compounds for the treatment and prevention of cancer
20090170798 - Highly safe intranasally administrable gene vaccines for treating alzheimer's disease
June 2009 - Clark & Elbing LLP patents
20090158640 - Process for producing biodiesel with improved filtration characteristics and biodiesel thus produced
20090158640 - Process for producing biodiesel with improved filtration characteristics and biodiesel thus produced
20090162320 - Gene transfer into airway epithelial stem cell by using lentiviral vector pseudotyped with rna virus or dna virus spike protein
20090162320 - Gene transfer into airway epithelial stem cell by using lentiviral vector pseudotyped with rna virus or dna virus spike protein
20090162328 - In vivo assay and molecular markers for testing the phenotypic stability of cell populations and selected cell populations for autologous transplantation
20090162328 - In vivo assay and molecular markers for testing the phenotypic stability of cell populations and selected cell populations for autologous transplantation
20090162943 - Reagents and methods for the detection of transmissible spongiform encephalopathy
20090162943 - Reagents and methods for the detection of transmissible spongiform encephalopathy
20090163451 - Methods for treating visceral pain
20090163451 - Methods for treating visceral pain
20090165154 - Transgenic ungulates having reduced prion protein activity and uses thereof
20090165154 - Transgenic ungulates having reduced prion protein activity and uses thereof
20090155200 - Methods of promoting cartilage healing or cartilage integration
20090155246 - Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof
20090155386 - Method for treating agricultural products of vegetable origin and the side-products and/or derivatives obtained by treatment
20090156536 - Aimp2-dx2 gene and sirna targeting aimp2-dx2
20090148383 - Anticoagulation agent and uses thereof
20090148425 - Therapeutic method for blood coagulation disorder
20090148860 - Methods of diagnosing muscle damage
20090148896 - Hyperthermophilic dna polymerase and methods of preparation thereof
20090149523 - Use of n-aminoimidazole cytoprotective compounds for treating cell death and/or gsk-3 mediated diseases
20090142335 - Methods of diagnosis and treatment of metabolic disorders
20090142343 - Anti-vegf antibodies
20090143997 - Methods and compositions for cancer treatment relating to brca1 brct domain recognition of phosphorylated bach1
May 2009 - Clark & Elbing LLP patents
20090136420 - Neoplasm-specific polypeptides and their uses
20090137451 - Methods for assessing suitability of cancer patients for treatment with histone deacetylase inhibitors
20090137504 - Microrna target site blocking oligos and uses thereof
20090137532 - Aldolase-inhibiting aromatic compounds
20090130676 - Interaction trap systems for detecting protein interactions
20090130724 - Enzymatic demethylation of flavonoids
20090131361 - Novel use of mln51 gene and protein
20090131414 - Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for treating hepatitis c
20090131503 - 3,5 - substituted indole compounds having nos and norepinephrine reuptake inhibitory activity
20090120874 - Membrane for filtering of water
20090123927 - Isolation of precursor cells and their use for tissue repair
20090123976 - Compositions and method for storage of nucleic acid from bodily fluids
20090124664 - (r)-arylalkylamino derivatives and pharmaceutical compositions containing them
20090117185 - 2-(aminomethyl)-5-chlorobenzylamide derivatives and their use as inhibitors of the clotting factor xa
20090117588 - Methods of diagnosing pre-eclampsia or eclampsia
20090117618 - Expression system for preparing il-15/fc fusion protein and its use
20090117652 - Use of cxcl6 chemokine in the prevention or repair of cartilage defects
20090118132 - Classification of acute myeloid leukemia
April 2009 - Clark & Elbing LLP patents
20090109518 - Imaging apparatus with a plurality of shutter elements
20090103099 - Integrated surface mode biosensor
20090103099 - Integrated surface mode biosensor
20090103099 - Integrated surface mode biosensor
20090104285 - Methods and compositions for use in treating cancer
20090104285 - Methods and compositions for use in treating cancer
20090104285 - Methods and compositions for use in treating cancer
20090105455 - Purified interleukin-15/fc fusion protein and preparation thereof
20090105455 - Purified interleukin-15/fc fusion protein and preparation thereof
20090105455 - Purified interleukin-15/fc fusion protein and preparation thereof
20090098020 - Binding assay
20090098083 - Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
20090098105 - Treatment of neurodegenerative diseases by the use of scd4 inhibitors
20090098634 - Scleroprotein of an adeno associated virus with modified chromatographic properties, the production thereof and use of the same
20090098650 - Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability and for the culture of adult stem cells
20090099084 - Treatment
20090099242 - Heterocyclic inhibitors of necroptosis
20090092663 - Tumor-targeted drug delivery systems and uses thereof
20090092975 - Selectable marker
20090087449 - Novel peptide compositions and the use thereof, in particular, in the preparation of active pharmaceutical compositions against the hepatitis c virus
20090087449 - Novel peptide compositions and the use thereof, in particular, in the preparation of active pharmaceutical compositions against the hepatitis c virus
20090087859 - Microfluidic device for detecting soluble molecules
20090087859 - Microfluidic device for detecting soluble molecules
20090088343 - Method of patterning and product(s) obtained therefrom
20090088343 - Method of patterning and product(s) obtained therefrom
20090088369 - Glp-1 and methods for treating diabetes
20090088369 - Glp-1 and methods for treating diabetes
March 2009 - Clark & Elbing LLP patents
20090081238 - Anti-notch1 nrr antibodies and methods using same
20090082277 - Potentiation of anticancer agents
20090071828 - Devices exhibiting differential resistance to flow and methods of their use
20090075879 - Novel peptide compositions and the use thereof, in particular, in the preparation of active pharmaceutical compositions against the hepatitis c virus
20090075911 - Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring
20090075951 - Methods and reagents for the treatment of inflammatory disorders
20090075955 - Therapeutic regimens for the treatment of immunoinflammatory disorders
20090076257 - Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring
20090077681 - Methods for diagnosing and treating heart disease
20090068156 - Treatment of muscular dystrophy with cord blood cells
20090068247 - Biocompatible devices coated with a tribonectin and methods for their production
20090068645 - Labeling and sequencing of nucleic acids
20090060969 - Porous biodegradable polymeric materials for cell transplantation
20090062198 - Maurotoxin, pi1 and hstx1 derivatives
February 2009 - Clark & Elbing LLP patents
20090053168 - Treatments of b-cell proliferative disorders
20090053254 - Recombinant human alpha-fetoprotein as an immunosuppressive agent
20090053718 - Novel oligonucleotide compositions and probe sequences useful for detection and analysis of micrornas and their target mrnas
20090053738 - Protease detection
20090054370 - Pyrimidines, such as uridine, in treatments for patients with bipolar disorder
20090054410 - Thiadiazole derivatives for the treatment of neurodegenerative diseases
20090047243 - Combinations for the treatment of b-cell proliferative disorders
20090047738 - Feeder cell derived from tissue stem cell
20090048161 - Cytokine receptor modulators and uses thereof
20090048177 - Methods for the treatment of mood disorders
20090041626 - Instrumentation systems and methods
20090041778 - Methods and compositions for the treatment of graft failure
20090041852 - Dry powder compositions and systems for poultry vaccination
20090042793 - Novel antiviral therapies
20090042814 - Treatment and diagnosis of obligate intracellular pathogens
20090035428 - Process and device for desolventising under reduced pressure
20090035799 - Novel trypsin family serine proteases
20090036382 - Tgf-beta modulators and use thereof
20090036430 - Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for medical treatment
January 2009 - Clark & Elbing LLP patents
20090027142 - Multi-band transducer for multi-band feed horn
20090029409 - Method for determination of oxidative stress
20090029460 - Neoplasm-specific polypeptides and their uses
20090029999 - Synephrine derivatives useful as anti-inflammatory agents
20090023149 - Methods, kits and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
20090023221 - Oligonucleotide probes useful for detection and analysis of microrna precursors
20090023594 - Reagents for labelling nucleic acids and uses thereof
20090023666 - Modulators of hypoxia inducible factor-1 and related uses
20090016959 - Delivery of antibodies to the central nervous system
20090019602 - Master activators of pathogen responsive genes
20090007555 - Biomimetic water membrane comprising aquaporins used in the production of salinity power
20090010927 - Mapkap kinase-2 as a specific target for blocking proliferation of p53-defective cells
20090010934 - Cell lines, ligands and antibody fragments for use in pharmaceutical compositions for preventing and treating haemostasis disorders
20090010996 - Human antibiotic proteins
20090011979 - Immunomodulatory protein and useful embodiments thereof
20090011981 - Novel inhibitors of angiogenesis
20090004669 - Methods of diagnosing pre-eclampsia or eclampsia
20090005346 - Azacytosine derivatives useful as antiviral agents
20090005358 - Compositions and methods for treating medical conditions
20090005648 - Method for the diagnosis of attention-deficit/hyperactivity disorder
October 2008 - Clark & Elbing LLP patents
20080260736 - Methods and compositions to regulate iron metabolism
20080262160 - Monodisperse polymers containing (alkyl)acrylic acid moieties, precursors and methods for making them and their applications
20080254069 - Vaccines for immunization against helicobacter
20080248033 - Vegf-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumors
20080248552 - Method of cell cultures and device for implementing it
20080249302 - Substituted indole compounds having nos inhibitory activity
20080241906 - Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same
20080242646 - Split dose corticosteroid therapy
September 2008 - Clark & Elbing LLP patents
20080234237 - Quinolone and tetrahydroquinolone and related compounds having nos inhibitory activity
20080234467 - Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
20080226547 - Alpha-emitting hydroxyapatite particles
20080226565 - Anticariogenic proteins & peptides & saccharides
20080226594 - Culturing circular ssdna viruses for the production of vaccines
20080226720 - Wound healing composition
20080227745 - Methods and compositions for soluble cpg15
20080227848 - Assays
20080227954 - Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
20080228253 - Surface modifying macromolecules with high degradation temperatures and uses thereof
20080220292 - Microbial fuel cells for oxidation of electron donors
20080220423 - Oligonucleotide probes useful for detection and analysis of microrna precursors
20080220473 - Endo-n-acetyl-beta-d-glucosaminidase enzymes of filamentous fungi
20080221076 - Crystalline sodium salt of cephalosporin antibiotic
20080213250 - Use of eph receptor inhibitors for the treatment of neurodegenerative diseases
20080213454 - Genetic transformation of apple without use of a selectable marker
20080213777 - Tumor suppressor pathway in c. elegans
20080214613 - Substituted benzimidazole compounds with dual nos inhibitory activity and mu opioid agonist activity
20080214802 - Substituted liposaccharides useful in the treatment and prevention of endotoxemia
August 2008 - Clark & Elbing LLP patents
20080206254 - Novel anti-factor viii antibodies
20080208268 - Means for functional restoration of a damaged nervous system
20080199426 - Methods and compositions for the treatment and diagnosis of vascular inflammatory disorders or endothelial cell disorders
20080199438 - Methods for suppressing tumor proliferation
20080199440 - Tissue repair using allogenic dermal fibroblasts
20080199449 - Methods and compositions for use in treating vascular diseases and conditions
20080193329 - Method and system for plasma treatment under high pressure
20080193374 - Liposomes enclosing a radionuclide and a cytotoxic agent for combination therapy
20080193455 - Novel anti-plgf a antibody
20080193477 - Vaccination against dengue virus infection
20080193485 - Food containing a probiotic and an isolated beta-glucan and methods of use thereof
20080193507 - Wound healing profile
20080194029 - Method for increasing the ratio of homologous to non-homologous recombination
20080194421 - Screening system for identifying drug-drug interactions and methods of use thereof
20080195349 - Calorimetric measuring device
20080188516 - Imiadazo[4,5-c] pyridine compound and method of antiviral treatment
20080188946 - Osteoinductive bone material
July 2008 - Clark & Elbing LLP patents
20080181886 - Polypeptides that bind baff and/or april
20080181888 - Polypeptides that bind br3 and uses thereof
20080182870 - Pyrido(3,2-d)pyrimidines useful for treating viral infections
20080183156 - Closed suction drainage apparatus with drainage tube having anti-clogging and irrigating functions
20080175862 - Recombinant flavivirus vaccines
20080176027 - Half closed thermoplastic honeycomb, their production process and equipment to produce
20080171036 - Taci antibodies and uses thereof
20080167230 - Methods and compositions for treating or preventing lesions of the respiratory epithelium
20080159899 - Process for producing sintered porous materials
20080160537 - Particle based binding assay
20080161193 - Differential phage capture proteomics
20080161199 - Fusion proteins and methods for determining protein-protein-interactions in living cells and cell lysates, nucleic acids encoding these fusion proteins, as well as vectors and kits containing these
20080161324 - Compositions and methods for treatment of viral diseases
June 2008 - Clark & Elbing LLP patents
20080152673 - Desiccated product
20080153128 - Cell-free protein synthesis
20080145860 - Encapsulated cell indicator system
20080146811 - Compounds and methods for treatment of thrombosis
20080138330 - Methods and compositions for treating conditions involving abnormal angiogenesis
20080138342 - Methods of treating pre-eclampsia and eclampsia
20080139458 - Methods of treatment for injured or diseased joints
20080139492 - Compositions and methods that enhance rna interference
20080139785 - Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
20080131409 - Methods and compositions for the treatment of medical disorders
20080132472 - Compounds for the treatment of psychiatric or substance abuse disorders
May 2008 - Clark & Elbing LLP patents
20080121494 - Mobile gastronomic table for serving out food
20080125388 - Methods and compositions for cpg15-2
20080102026 - Hypoxia-selective, weakly basic 2-nitroimidazole delivery agents and methods of use thereof
20080102054 - Compositions containing agm cells and methods of use thereof
20080102162 - Prebiotic preparation
20080102504 - Methods and apparatus for characterizing polynucleotides
April 2008 - Clark & Elbing LLP patents
20080095786 - Compositions and methods for preventing and treating endotoxin-related diseases and conditions
20080095803 - Protein matrix vaccines and methods of making and administering such vaccines
20080096841 - Treatment and prevention of heat shock protein-associated diseases and conditions
20080085237 - Weakly basic 2-nitroimidazoles for the non-invasive detection of tissue hypoxia
20080085835 - Rps gene family, primers, probes and detection methods
20080081097 - Phase transfer apparatus and process
20080081338 - Diagnostic method
March 2008 - Clark & Elbing LLP patents
20080075792 - Method for inhibiting the activity of dpp-iv and lowering blood glucose level
20080076674 - Novel oligonucleotide compositions and probe sequences useful for detection and analysis of non coding rnas associated with cancer
20080069820 - Multispecific antibodies
20080070293 - Enzyme-based monitoring device for thermal processing of objects
20080064038 - Autism genes and regulated secretion
20080064081 - Structural protein of adeno-associated virus with modified antigenicity, its production and its use
20080064648 - Methods and compositions relating to lipid accumulation
20080064652 - Methods and compositions for treating hypercholesterolemia
20080064965 - Devices and methods for measuring pulsus paradoxus
20080058429 - Diagnosis of primary open angle glaucoma
February 2008 - Clark & Elbing LLP patents
20080051599 - Production of esters of fatty acids and lower alcohols
20080040941 - Measurement configuration based on linear scales able to measure to a target also moving perpendicular to the measurement axis
20080044390 - Methods and compositions for the treatment of neurodegenerative disorders
20080038234 - Bone marrow-related cells associated with tissue maintenance and/or repair
20080038249 - Treatment of neurodegenerative diseases by the use of laptm4a
20080039911 - Adhesion prevention and an intra-luminal cooling system therefor
20080040821 - Transgenic ungulates capable of human antibody production
20080028992 - Delayed-setting calcium phosphate pastes
20080031850 - Tissue regeneration method
20080031819 - Compositions and methods that enhance articular cartilage repair
20080031822 - Methods of modeling migraine pain and identifying candidate compounds for the treatment of migraine
20080031855 - Anticancer agent containing minus-strand rna virus
20080032955 - Vitamin d3 analogues for the prevention and treatment of bone disorders
January 2008 - Clark & Elbing LLP patents
20080025929 - Topical formulations for the treatment of skin conditions
20080025965 - Methods and compositions for the treatment of diseases or conditions associated with increased c-reactive protein levels
20080025969 - Treatment of neurodegenerative diseases by the use of gpr49
20080026003 - Methods for inhibiting pain
20080020991 - Methods of treating, reducing, or preventing autoimmune conditions
20080021351 - Method for diagnosing adhd and related behavioral disorders
20080021564 - Humeral head resurfacing implant and methods of use thereof
20080014183 - Anticancer agent containing dendritic cell having rna virus transferred thereinto
20080015152 - Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
20080009010 - Methods for diagnosis and prognosis of psychotic disorders
20080009487 - Treatment of athersclerotic disease
20080003213 - Methods and compositions for the treatment of diseases or conditions associated with increased c-reactive protein, interleukin-6, or interferon-gamma levels
20080003256 - Biocompatible coating of medical devices
20080004285 - Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for medical treatment
December 2007 - Clark & Elbing LLP patents
20070298015 - Treatment of muscular dystrophy with mobilized peripheral blood pluripotent cells
20070298029 - Treatment of neurodegenerative diseases by the use of degs inhibitors
20070298051 - Adjuvants of immune response
20070299010 - Cpg15 and cpg15-2 compounds and inhibitors as insulin receptor and insulin-like growth factor receptor agonists and antagonists
20070299043 - Anti-scarring drug combinations and use thereof
20070292426 - Methods and compositions based on shiga toxin type 1 protein
20070292851 - Methods for identifying candidate compounds for treating, reducing, or preventing pathogenic infections
20070293418 - Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
20070280927 - Treatment of neurodegenerative diseases by the use of atp7a
20070281329 - Characterization of individual polymer molecules based on monomer-interface interactions
November 2007 - Clark & Elbing LLP patents
20070274971 - Method of proliferating precursor cells
20070274991 - Treatment of tumors expressing mutant egf receptors
20070275015 - West nile virus vaccine
20070275068 - Controlled release delivery system for bio-active agents
20070275071 - Use of microparticles for antigen delivery
20070275380 - Method for distinguishing aml subtypes with aberrant and prognostically intermediate karyotypes
20070275416 - Affinity marker for purification of proteins
20070275900 - Prodrugs cleavable by cd26
20070269414 - Method for producing gene transferred denritic cells
20070269425 - Anti-idiotype antibodies of the human monoclonal antibody sc-1, and their production and use
20070269434 - Tat-041 and methods of assessing and treating cancer
20070269458 - Vaccines against japanese encephalitis virus and west nile virus
20070269539 - Ginkgo biloba extract as a treatment for therapeutic-induced neurotoxicity
20070269830 - Process for the identification of new medical targets
20070264244 - Pigment epithelial cell of the eye, its production and use in therapy of an eye or cns disease
20070264276 - Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
20070264306 - Scaffold engineering
20070264675 - Microfluidic device for cell separation and uses thereof
20070259358 - Integrase cofactor
20070259424 - Microfluidic device for cell separation and uses thereof
20070259816 - Drg11-responsive axonal guidance and outgrowth of neurite (dragon) gene family
20070259831 - Treatment and screening methods for promoting neurogenesis
20070259841 - Combinations for the treatment of rheumatoid arthritis
20070253939 - Cell delivery system
20070254002 - Biocompatible devices coated with activated protein c
20070254063 - Use of hop polyphenols in beer
20070254288 - Diagnostic methods for pain sensitivity and chronicity and for tetrahydrobiopterin-related disorders
20070254940 - 1,5 and 3,6- substituted indole compounds having nos inhibitory activity
20070255254 - Cell delivery system
October 2007 - Clark & Elbing LLP patents
20070248574 - Methods of making and using skin-derived stem cells
20070248627 - Gene therapy for tumors using minus-strand rna viral vectors encoding immunostimulatory cytokines
20070248668 - Pharmaceutical compositions and uses thereof
20070249557 - Compositions and methods for viscosupplementation
20070244148 - Imidazo 4,5-c pyridine compounds and methods of antiviral treatment
20070244187 - Intermediates for the preparation of halichondrin b
20070238670 - Novel compositions and methods for promoting, inhibiting and detecting protein entry into cells
20070238684 - Aav scleroprotein, production and use thereof
20070238747 - Rifamycin analogs and uses thereof
20070231308 - Glucagon-like-peptide-2 (glp-2) analogues
20070231336 - Immunization against clostridium difficile disease
20070231851 - Microfluidic device for cell separation and uses thereof
20070231863 - Drg11-responsive axonal guidance and outgrowth of neurite (dragon) gene family
September 2007 - Clark & Elbing LLP patents
20070225217 - Methods, compositions, and kits for the treatment of medical conditions
20070219277 - Small molecules used to increase cell death
20070220620 - Tat-046 and methods of assessing and treating cancer
20070212733 - Methods and compositions related to b cell assays
20070212747 - Cassette containing growth medium
20070213296 - Compositions and methods for the treatment of immunoinflammatory disorders
20070213308 - Methods, compositions, and kits for the treatment of musculoskeletal disorders and symptoms associated therewith
20070213394 - Salvinorin derivatives and uses thereof
20070213964 - Method and device for predicting risk of decompression sickness
20070208134 - Anti-scarring drug combinations and use thereof
August 2007 - Clark & Elbing LLP patents
20070202546 - Immunoassay carrier
20070196418 - Drug delivery methods and devices
20070196421 - Soft tissue implants and drug combination compositions, and use thereof
20070196820 - Devices and methods for enrichment and alteration of cells and other particles
20070196878 - Immune diagnostic assay to diagnose and monitor tuberculosis infection
20070196917 - Methods of constructing a gene mutation library and compounds and compositions thereof
20070197957 - Implantable sensors, implantable pumps and anti-scarring drug combinations
20070198063 - Electrical devices and anti-scarring drug combinations
20070189942 - Sterilizer for medical devices
20070190575 - Osteoactivin protein and nucleic acids encoding the same, compositions and methods of stimulating bone differentiation
20070192883 - Tat-028 and methods of assessing and treating cancer
20070192884 - Tat-038 and methods of assessing and treating cancer
20070192885 - Tat-039 and methods of assessing and treating cancer
20070192886 - Tat-044 and methods of assessing and treating cancer
20070192887 - Tat-042 and methods of assessing and treating cancer
20070181462 - A process for the production of needle coke
20070184052 - Soluble tgf-b type iii receptor fusion proteins
20070184544 - Culturing circular ssdna viruses for the production of vaccines
20070185018 - Use of secretin in treatments of disorders associated with the amygdala
20070185062 - Phosponate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production
20070185343 - Metal complexes for use in olefin metathesis and atom group transfer reactions
20070186288 - Zebrafish models of acute myelogenous leukemia
20070186294 - Tat-030 and methods of assessing and treating cancer
20070186295 - Tat-036 and methods of assessing and treating cancer
20070175829 - Pressure driven separation of liquid feeds
20070179152 - Combination therapy for the treatment of neoplasms
20070179455 - Needle constructed with a transparent or translucent material
20070180545 - Tat-031 and methods of assessing and treating cancer
July 2007 - Clark & Elbing LLP patents
20070171225 - Time-dependent three-dimensional musculo-skeletal modeling based on dynamic surface measurements of bodies
20070172824 - Method for amplifying unknown dna sequence adjacent to known sequence
20070172853 - Use of deletion polymorphisms to predict, prevent, and manage histoincompatibility
20070172903 - Microfluidic device for cell separation and uses thereof
20070173466 - Methods of treating inflammatory diseases associated with bone destruction
20070173489 - Inhibitors of the gpib-vwf interaction, their preparation and use
20070166286 - Self-rearranging dna vectors
20070166702 - Methods for predicting the efficacy or outcome of hcv therapy
20070167409 - Compounds and methods for treating toll-like receptor 2-related diseases and conditions
20070169211 - Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof
20070160503 - Microfluidic systems for size based removal of red blood cells and platelets from blood
20070160600 - Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations
20070160607 - Humanized monoclonal antibodies that protect against shiga toxin induced disease
20070160953 - Method for manufacturing a prosthesis made prior to implant placement
20070161005 - Culturing circular ssdna viruses for the production of vaccines
20070161050 - Monoclonal antibodies to mesenchymal stem cells
20070161110 - Methods for producing minus-strand rna viral vectors using hybrid promoter comprising cytomegalovirus enhancer and chicken beta-actin promoter
20070153652 - Recording and/or reproducing methods and apparatuses
20070153653 - Recording and/or reproducing methods and appratuses
20070154482 - Methods and compositions for the treatment and diagnosis of diseases characterized by vascular leak, hypotension, or a procoagulant state
20070154904 - Methods for identifying novel nucleic acid regulatory elements and compounds that affect the regulation
20070155715 - Rifamycin analogs and uses thereof
June 2007 - Clark & Elbing LLP patents
20070148733 - Yeast expression vectors for production of itf
20070149469 - Medical use of tbk-1 or of inhibitors thereof
20070141634 - Assay
20070141705 - Method for producing viral vectors
20070142392 - Uses of rifamycins
20070135337 - Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
20070128173 - Use of polysulphated alginate in cellular matrices
20070128245 - Porous calcium phosphate bone material
20070128591 - Methods for diagnosing and treating diseases and conditions of the digestive system and cancer
May 2007 - Clark & Elbing LLP patents
20070122340 - Necrosis avid tracer agent
20070122814 - Methods for distinguishing prognostically definable aml
20070123469 - N- or c- terminally modified small peptides
20070116688 - Methods of organ regeneration
20070117144 - Oligonucleotides useful for detecting and analyzing nucleic acids of interest
20070117163 - Anti-aurora-a monoclonal antibody, method for obtaining same and uses thereof for diagnosing and treating cancers
20070117752 - Glucagon-like-peptide-2 (glp-2) analogues
20070117836 - Napthalimide derivatives, methods for their production and pharmaceutical compositions therefrom
20070110685 - Combination therapy for the treatment of immunoinflammatory disorders
20070110819 - Composite structures containing hyaluronic acid the derivatives thereof as new bone substitutes and grafts
20070111327 - Methods of detecting lubricin
20070111940 - Peptide agonists of glp-1 activity
20070112018 - Treatment of peripheral arterial occlusive disease
20070104699 - Compositions for and methods of granzyme b inhibition
20070104707 - Methods of diagnosing and treating complications of pregnancy
20070105167 - Virulence associated nucleic acid sequences and uses thereof
20070105208 - Minus strand rna virus vector carrying gene modified in high mutation region
20070105761 - Methods, compositions, and kits for the treatment of opthalmic disorders
20070105849 - Rifamycin analogs and uses thereof
20070106065 - Tat- 001 and methods of assessing and treating cancer
20070099196 - Novel oligonucleotide compositions and probe sequences useful for detection and analysis of micrornas and their target mrnas
20070099201 - Methods for detecting and quantifying binding and inhibition of binding of species to nucleic acids
20070099207 - Devices and methods for enrichment and alteration of circulating tumor cells and other particles
20070099289 - Device and method for contacting picoliter volumes of fluid
20070099905 - Combinations of drugs for the treatment of neoplasms
20070099906 - Combinations for the treatment of noeplastic disorders
April 2007 - Clark & Elbing LLP patents
20070087378 - Polynucleotide and polypeptide fat metabolism regulators and uses thereof
20070088248 - Devices for transcutaneous delivery of vaccines and transdermal delivery of drugs and uses thereof
20070081999 - Antithrombotic von willebrand factor (vwf) collagen bridging blockers
20070082054 - Particle size reduction of bioactive compounds
20070082840 - Combination therapy for inhibition of platelet aggregation
20070078185 - Methods and compositions for controlling invertebrate pests
February 2007 - Clark & Elbing LLP patents
20070043000 - Immunosuppresive effects of pteridine derivatives
20070043002 - Aldolase-inhibiting aromatic compounds
20070043188 - Multicoordinated metal complexes for use in metathesis reactions
20070044167 - Method for producing avian chimera using spermatogonial cells and avian chimera
20070036756 - Method for treating ischemic diseases
20070037210 - Cytokine receptor modulators, method of identifying same, and method of modulating cytokine receptors activity with same
20070037891 - Methods and compositions for the delivery of biologically active agents
20070031438 - Antibodies as chimeric effector cell receptors against tumor antigens
20070032477 - Pteridine derivatives useful for making pharmaceutical compositions
20070025914 - Bronchioalveolar stem cells and uses thereof
20070026381 - Devices and methods for enrichment and alteration of cells and other particles
20070026413 - Devices and methods for enrichment and alteration of circulating tumor cells and other particles
20070026414 - Devices and methods for enrichment and alteration of circulating tumor cells and other particles
20070026415 - Devices and methods for enrichment and alteration of circulating tumor cells and other particles
20070026416 - Devices and methods for enrichment and alteration of circulating tumor cells and other particles
20070026417 - Devices and methods for enrichment and alteration of circulating tumor cells and other particles
20070026418 - Devices and methods for enrichment and alteration of circulating tumor cells and other particles
20070026419 - Devices and methods for enrichment and alteration of circulating tumor cells and other particles
20070026469 - Devices and methods for enrichment and alteration of circulating tumor cells and other particles
20070027103 - Methods and compositions for silencing genes without inducing toxicity
20070027127 - Treatment of inflammatory oral diseases with a combination of inhibitors of tnf-alpha and immunosuppressive agents
January 2007 - Clark & Elbing LLP patents
20070020285 - Novel peptide compositions and the use thereof, in particular, in the preparation of active pharmaceutical compositions against the hepatitis c virus
20070015246 - Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
20070015718 - Diagnosis and management of infection caused by chlamydia
20070009592 - Immediate release pharmaceutical granule compositions and a continuous process for making them
20070009949 - Paramyxovirus-derived rnp
20070010502 - Methods and reagents for the treatment of immunoinflammatory disorders
20070010541 - Methods for treating vascular diseases
20070003560 - Humanized monoclonal antibodies that protect against shiga toxin induced disease
20070004623 - Use of hydroxylated amino acids for treating diabetes
20070004721 - Pteridine derivatives for the treatment of septic shock and tnf-a-related diseases
20070004905 - Solid-phase peptide synthesis and agent for use in such synthesis
20070005139 - Tissue engineered tendons and ligaments
December 2006 - Clark & Elbing LLP patents
20060292149 - Variable antibodies
20060292179 - Vaccines for immunization against helicobacter
20060294603 - Cloning of transgenic animals comprising artificial chromosomes
20060283686 - Mobile gastronomic table for serving out food
20060286125 - Nucleic acid molecules and polypeptides for immune modulation
20060286167 - Compositions and methods for the treatment of neurodegenerative diseases
20060286177 - Methods and reagents for the treatment of inflammatory disorders
20060287314 - Immunosuppressive effects of pteridine derivatives
20060287503 - Retinoid x receptor-interacting polypeptides and related molecules and methods
20060280798 - Nanoparticles for delivery of a pharmacologically active agent
20060281046 - Stent for guiding the location/direction of implant, and production method thereof
20060281722 - Compounds and uses thereof
20060275748 - Integrase cofactor
20060276562 - Composite materials for bone defect filling and bone replacement
November 2006 - Clark & Elbing LLP patents
20060269520 - Xiap therapy
20060269944 - Mass intensity profiling system and uses thereof
20060269945 - Constellation mapping and uses thereof
20060270742 - Compositions and methods for the treatment of neurodegenerative diseases
20060263366 - Neoplasm specific antibodies and uses thereof
20060263859 - Method for preparing 3'-amino-2',3'-dideoxyguanosine
20060263876 - Neural crest stem cells and uses thereof
20060264384 - Compositions and methods for treatment for neoplasms
20060257381 - Method for transplanting lymphohematopoietic cells into mammal
20060257660 - Antistatic agent for vinyl chloride-based resins, vinyl chloride-based resin composition containing the same, and method for manufacturing this composition
20060257901 - Methods of diagnosing fetal trisomy 13 or a risk of fetal trisomy 13 during pregnancy
20060258721 - Substituted indole compounds having nos inhibitory activity
20060253014 - Methods for identifying anatomical and molecular targets for analgesic therapy
20060246031 - Use of cxcl6 chemokine in the prevention or repair cartilage defects
20060246046 - Modified tridegins, production and use thereof as transglutaminase inihibitors
October 2006 - Clark & Elbing LLP patents
20060239985 - Method of preparing cell for transplantation
20060239998 - Anti-idiotypic antibodies against factor viii inhibitor and uses thereof
20060240014 - Methods and compounds for the treatment of vascular stenosis
20060240037 - Methods and compositions for the treatment and prevention of degenerative joint disorders
20060240121 - Chemotherapeutic composition using nanocrystalline calcium phosphate paste
20060241122 - Combination therapy for the treatment of neoplasms
20060234991 - Combinations for the treatment of immunoinflammatory disorders
20060235001 - Compositions for the treatment of neoplasms
20060236411 - Antagonists il-15
20060228297 - Thorium-227 for use in radiotherapy of soft tissue disease
20060222655 - Compositions and methods for preventing and treating endotoxin-related diseases and conditions
20060223178 - Devices and methods for magnetic enrichment of cells and other particles
20060223733 - Compositions and methods for use in unclogging drains and pipes
20060223884 - Compounds and compositions for use in the prevention and treatment of obesity and related syndromes
September 2006 - Clark & Elbing LLP patents
20060216227 - Catalysts for hydrogen production
20060216824 - Paramyxovirus vector encoding ribozyme and utilization thereof
20060217344 - Compounds for the treatment of tobacco dependence and withdrawal
20060218657 - Method for improving germline transmission efficiency of avian primordial germ cells
20060211608 - Use of a parathyroid hormone peptide analogs for the treatment of viginal atrophy
20060212952 - Methods for cloning mammals using reprogrammed donor chromatin or donor cells
20060201504 - High-flow oxygen delivery system and methods of use thereof
20060204921 - Dental articulator having dual balls
20060205764 - Inhibition of platelet aggregation
20060199771 - Stereoselective antifibrillogenic peptides and peptidomimetics thereof
20060199853 - Analogs of 4-hydroxyisoleucine and uses thereof
20060200873 - Salicylic acid biosynthetic genes and uses thereof
###
This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Clark & Elbing LLP in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Clark & Elbing LLP with additional patents listed. Browse our Agent directory for other possible listings.
###
FreshPatents.com Support
|
REGISTER now for FREE 
